Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-14

FDA Approved: CYANOCOBALAMIN — Supplemental Application (Plano Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for cyanocobalamin from Plano Pharmaceuticals Inc., indicating changes to an already approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYANOCOBALAMIN (cyanocobalamin)

Snippet

SUPPL AP for CYANOCOBALAMIN (CYANOCOBALAMIN)